It will be very interesting to understand whether this decision to write-off the DTA was discussed with the banks involved in the new financing arrangement... debt appear to be approximately $44m, and with total equity now much lower at approximately $33m, the gearing is well and truly >100%.
If you assume that BFC are able to recover 90% of the value of the assets in the discontinued ops in cash, and repay debt with all of these funds, gearing still remains around 100%.
Also, interesting the the results which have been provided at this stage remain unaudited - there must still be some major issues preventing the auditors from signing the audit opinion for the financial statements.
My concern is that the circa $8m improvement in the whole of business EBITDA (including discontinued ops) against FY22 looks suspiciously like the sales of lactoferrin held over from the prior year - which means the improved result is not sustainable.
More red flags than gold stars from my perspective, but the backslapping and self-congratulation in this morning's announcement presentation suggests management and the board think otherwise.....
- Forums
- ASX - By Stock
- Ann: FY23 Full-Year Results Presentation
It will be very interesting to understand whether this decision...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BFC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.991M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BFC (ASX) Chart |
Day chart unavailable